Tulsyan NEC is an integrated steel manufacturer producing TMT bars, billets, and sponge iron, while also operating a thermal power plant and a synthetic packaging division that makes woven sacks.
The company operates in a highly fragmented, commodity-driven industry with no discernible cost advantage, as evidenced by persistent net losses and an interest coverage ratio well below 1.0. High ROCE and ROE figures are misleading artifacts of a severely depleted equity base and recent debt restructuring rather than operational efficiency.
Capital has been primarily directed toward debt servicing and essential maintenance capex for aging facilities. The track record is marred by a massive one-time settlement with lenders in 2023, indicating that prior reinvestments failed to generate sufficient cash flow to cover the cost of capital.
The company's survival depended on a debt restructuring that proved to be a temporary reprieve rather than a cure. By 2029, the inability to generate operating cash flow to cover even basic interest obligations led to a total liquidity collapse. The unconfirmed trade receivables, which represented over half the company's value, were eventually written off as uncollectible, revealing a hollow balance sheet. Without the ability to raise fresh capital or secure further director loans, the aging facilities became unviable, and the equity was wiped out in a final insolvency proceeding.
RichFakir rates Tulsyan NEC Ltd's business quality as poor — 28/100 on our quality score (profitability, growth, balance-sheet strength and capital allocation). We assess its competitive moat as none.
On our model, Tulsyan NEC Ltd is trading about 93% below our estimate of fair value; we rate its price cheap. This is an educational estimate from public filings, not a recommendation.
RichFakir's educational verdict on Tulsyan NEC Ltd is: Avoid. We are steering clear of this one — the red flags below outweigh anything the price or numbers offer.
RichFakir's educational estimate of Tulsyan NEC Ltd's fair value is about ₹467 per share, derived from public filings. It's our estimate for research — not a price target or a recommendation to buy or sell.
View the full live analysis →